Oxycodone HCL-Acetaminophen Tablets SPE2D221R0114
Summary
AI-generated · Sep 03, 2025Oxycodone HCL/acetaminophen tablets are being procured under contract SPE2D2-22-D-0150 with line items 0001–0005, including three option years for continued supply. The award has been made to SPECGX LLC for the specified line items.
The contract will include Drug Supply Chain Act language and a FAR 52.204-27 Prohibition on a ByteDance Covered Application clause, signaling requirements for secure drug-supply-chain practices and restrictions on certain software used in the contract.
SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
From Award Notice posted on Sep 02, 2025Notice history
1Details
Award Information
Award Notices
Posted: Sep 02, 2025
SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into soli...
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| SPECGX LLC | SJ9MSB1UXGL8 | 84GK4 | Webster Groves, MO |
Documents
7Contacts
Phone
Phone
Agency
Place of Performance
USA